Answers are grounded in this paper and cite their sources.
The number of people with diabetes mellitus worldwide is expected to more than double from 171 million in 2000 to 366 million in 2030, based on demographic changes alone.1 Consequently, the estimated cost of diabetes care in the United States is expected to increase from $132 billion in 2002 to $156 billion (in 2002 dollars) by 2010 and $192 billion by 2020.2 Given the increasing prevalence of obesity and its significance as a risk factor for diabetes, the expected number of cases of diabetes and actual cost in future years could be even higher. Tight glycemic control is of paramount importance if patients are to minimize the risk of developing the long-term complications of type 2 diabetes mellitus.3 Nevertheless, the National Health and Nutrition Examination Survey showed a decrease in glycemic control rates (percentage of patients with a glycosylated hemoglobin [HbA1c] level of <7%) from 44.5% in 1988–94 to 35.8% in 1999–2000.4 More recent data gathered during 2003–04 by the American Association of Clinical Endocrinologists (AACE) showed that two thirds of patients with type 2 diabetes did not have an HbA1c level of ≤6.5%.5
No takes yet. Share an insight, caveat, or question.
Jerry Meece (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: